INVO Fertility, Inc.IVF
▲ PositiveCapitalrelevance
Q2 EPS beat by $5.55 despite revenue miss
Impact on stocks 1
Health Care
INVO Fertility, Inc.INVO BioScience reported second-quarter GAAP earnings per share of $0.35, beating analyst expectations by $5.55. Revenue came in at $2.18 million, up 17.2% year-over-year, but missed estimates by $0.53 million. The results were released via a company press release.
INVO Fertility, Inc.Q2 EPS beat by $5.55 despite revenue miss